Anti-Tumor Effects of Engineered VNP20009-Abvec-Igκ-mPD-1 Strain in Melanoma Mice via Combining the Oncolytic Therapy and Immunotherapy

Programmed cell death protein 1/Programmed cell death ligand 1 (PD-1/PD-L1) immune checkpoint inhibitors are the most promising treatments for malignant tumors currently, but the low response rate limits their further clinical utilization. To address this problem, our group constructed an engineered...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	De-Xi Zhou, Xiao-He Wang, Xuan Xu, Wen-Jie Chen, Jing Wei, Ting-Tao Chen, Hong Wei
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	MDPI AG 2022-12-01
Reeks:	Pharmaceutics
Onderwerpen:	VNP20009 mPD-1 bacterial therapy melanoma
Online toegang:	https://www.mdpi.com/1999-4923/14/12/2789
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!